The Medical Device Business Journal — Medical Device News & Articles | MassDevice
BG Medicine Inc. (NSDQ:BGMD) inked another deal to develop a version of its galectin-3 test for heart failure, this time with Health Diagnostics Laboratory Inc.
The diagnostic test screens for the presence of a protein called galectin-3, which is both a predictor and the cause of a certain type of heart failure.
Forest Laboratories Inc. (NYSE:FRX) is planning a $1.2 billion takeover of Clinical Data Inc. (NSDQ:CLDA).
Under the terms of the merger agreement between the two companies, Forest Labs will pay $30 per share in cash, with additional milestone payments of up to $6 per share based on the commercial success of Clinical Data’s new antidepressant drug, Viibryd, according to the companies.
A of Sparton Corp. (NYSE:SPA) subsidiary acquired Denver, Colo.-based Delphi Medical Systems contract manufacturing business.
The Schaumburg, Ill.-based manufacturing services provider’s Sparton Medical Systems Colorado LLC subsidiary bought Delphi’s manufacturing assets in a deal worth $8 million. Delphi primarily makes OEM medical devices for the therapeutic device market, including blood separation equipment, spinal surgery products and 3D eye mapping devices. The company also supports an environmental sensor firm for the meteorology and controlled environment applications markets.
